国产甲磺酸伊马替尼治疗慢性髓性白血病慢性期早期疗效和安全性的前瞻性、多中心临床研究

OBJECTIVE: To evaluate the early hematologic, cytogenetic and molecular responses in newly diagnosed patients with chronic myelogenous leukemia in chronic phase (CML-CP) and initially treated with a generic imatinib (Xinwei), manufactured by Jiansu Hansoh Pharmaceutical Group Co., Ltd. METHODS: 107...

Full description

Saved in:
Bibliographic Details
Published in:Zhonghua Xue Ye Xue Za Zhi
Format: Artigo
Language:Inglês
Published: Editorial office of Chinese Journal of Hematology 2015
Subjects:
论著
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7348277/
https://ncbi.nlm.nih.gov/pubmed/26462633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.08.005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items